Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. (Q41846031)
Jump to navigation
Jump to search
scientific article published on 3 April 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. |
scientific article published on 3 April 2017 |
Statements
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease (English)
Fiona Powrie
Gerhard MĂĽller-Newen
Ahmed N Hegazy
Benjamin M J Owens
Samuel J Bullers
Bryan Linggi
Sofia Buonocore
Margherita Coccia
SĂ©bastien This
Matthias Friedrich
Grigory Ryzhakov
Frédéric Baribaud
Carrie Brodmerkel
Constanze Cieluch
Nahid Rahman
Raymond J Owens
Anja A KĂĽhl
Scott E Plevy
Oxford IBD Cohort Investigators